Statement Of Income And Retained Earnings

Oncolys BioPharma Inc. - Filing #7587326

Concept 2022-01-01 to
2022-09-30
2021-01-01 to
2021-09-30
Statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
-937,381,000 JPY
-963,649,000 JPY
Non-operating income
Non-operating income
100,646,000 JPY
29,703,000 JPY
Non-operating expenses
Non-operating expenses
17,720,000 JPY
42,945,000 JPY
Ordinary profit (loss)
-854,455,000 JPY
-976,891,000 JPY
Extraordinary income
Extraordinary income
21,406,000 JPY
JPY
Profit (loss) before income taxes
-833,049,000 JPY
-976,891,000 JPY
Income taxes - current
2,199,000 JPY
2,787,000 JPY
Profit (loss)
-835,248,000 JPY
-979,679,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.